Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.

PlanetDrugsDirect.com has been providing quality medications to satisfied American patients at heavily discounted prices for over twenty years.

Unless you live under a rock, you’ve heard about injectable GLP-1 agonist drugs like semaglutide and tirzepetide (brand names Ozempic and Mounjaro, respectively) that fall under a class of medications ...

Certain foods can mimic the effects of Ozempic, a weight loss drug, helping reduce hunger. Here's what worked for a woman during her weight loss journey. Aimee Meier has shared her list of foods ...

GLP-1 agonist medications ... dose of 2.0 mg weekly. Common side effects include nausea, vomiting, diarrhea, and constipation. Consult your healthcare provider or the Ozempic medication guide ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Another busy day, so let’s get straight into the news ...

Type 2 diabetes is a leading cause of chronic kidney disease, which affects more than 1 in 7 U.S. adults. The new approval allows doctors to prescribe Ozempic specifically to lower the risk of ...

AS DEMAND GOES UP.. BUT HE SA Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the U.S. Food and Drug Administration to ...